InvestorsHub Logo
Followers 57
Posts 5700
Boards Moderated 0
Alias Born 12/13/2004

Re: None

Tuesday, 12/06/2022 11:37:07 AM

Tuesday, December 06, 2022 11:37:07 AM

Post# of 462062
The CTAD data could very well gain regulatory approval in Australia and possibly Europe. And the August 2022 CC reveals partnering discussions have been going on for at least 4 months...and probably much longer. Certainly the CTAD data will advance those discussions. Either regulatory approval or partnerships will certainly advance the share price significantly. And there is very important Rett and Parkinson data coming very soon. There are certainly many potential catalysts ... several expected before year end.

"The refusal of the real is the number one dogma of our time" Rene Girard

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News